Effect of long-term β2-agonist closing on human cardiac β-adrenoceptor expression in vivo: Comparison with changes in lung and mononuclear leukocyte β-receptors

Journal of Nuclear Cardiology

Volumn 4, Issue 6, 1997, Pages 532-538

  Qing, Feng ^a   Rahman, Shakil U ^a   Hayes, Michael J ^a   Rhodes, Christopher G ^a   Ind, Philip W ^a   Jones, Terry ^a   Hughes, J M B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Human heart; Positron emission tomography; adrenergic agonists; adrenergic receptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; RADIOLIGAND; SALBUTAMOL;

ADULT; ARTICLE; CLINICAL TRIAL; HEART; HUMAN; HUMAN EXPERIMENT; LIGAND BINDING; LUNG; MALE; MONOCYTE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; TACHYPHYLAXIS;

EID: 0031439095     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90012-X     Document Type: Article

References (25)

1. Sears MR, Taylor DR , Print CG , et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336: 1391-6.
2. Crane J, Pearce N, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989;1:917-22.
3. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
4. 2-adrenoceptors in human heart: properties, function and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-42.
5. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985;132:541-7.
6. Spina D, Rigby PJ, Paterson JW, et al. Autoradiographic localization of beta-adrenoceptors in asthmatic human lung. Am Rev Respir Dis 1989;140:1410-5.
7. Brodde OE, Daul A, Michel MR, et al. Agonist-induced desensitization of beta-adrenoceptor function in humans: subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Circulation 1990;81: 914-21.
8. Martinsson A, Larsson K, Hjemdahl P. Studies in vivo and in vitro of terbutaline-induced beta-adrenoceptor desensitization in healthy subjects. Clin Sci 1987;72:47-54.
9. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholaraine sensitivity and β-adrenergic-receptor density in failing human heart. N Engl J Med 1982;307:205-11.
10. Lipworth, BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled albuterol in asthmatics. Am Rev Respir Dis 1989;140:586-92.
11. Hayes MJ, Qing F, Rhodes CG, et al. In vivo quantification of human pulmonary β-adrenoceptors: effect of β-agonist therapy. Am J Respir Crit Care Med 1996;154:1277-83.
12. 11C]CGP-12177 and PET. J Appl Physiol 1993;75:559-65.
13. Qing F, Rhodes CG, Hayes MJ, et al. In vivo quantification of human pulmonary β-adrenoceptor density using PET: comparison with in vitro radioligand binding. J Nucl Med 1996;37:1275-81.
14. Robb RA, Hanson DP. A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas Phys Eng Sci Med 1991;14:9-30.
15. Delforge J, Syrota A, Lancon J-P, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP12177, and a new graphical method. J Nucl Med 1991;32:739-48.
16. Rhodes CG, Wollmer P, Fazio F, et al. Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J Comput Assist Tomogr 1981;5:783-91.
17. Lowry O, Rosenbrough N, Fraa A, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
18. Stiles GL, Taylor S, Lefkowitz RJ. Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. Life Sci 1983;33:467-73.
19. 1-receptor downregulation in heart failure. Circ Res 1986;59:297-309.
20. 2-adrenoceptor subpopulation. J Cardiovasc Pharmacol 1989;14:549-59.
21. Lefroy DC, de Silva R, Choudhury L, et al. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 1993;22:1653-60.
22. Connolly M, Crowley J, Nielson C, et al. Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial response to methacholine in young and elderly normal subjects and asthmatic patients. Thorax 1994;49:26-32.
23. Khan MM, Sansoni P, Silverman ED, et al. adrenergic receptor on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol 1986;35:1137-42.
24. Maisel AS, Knowlton KU, Flowler P, et al. Adrenergic control of circulating lymphocyte subpopulations: effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest 1990;85:462-7.
25. Rahman SU, Qing F, Rhodes CG, et al. Regulation of Pulmonary β2 adrenergic receptor expression: concordance between receptor density, function and genotypes. Am J Respir Crit Care Med 1997;155:A855.